nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—DRD3—Gilles de la Tourette syndrome	0.257	0.317	CbGaD
Mianserin—SLC6A3—Gilles de la Tourette syndrome	0.239	0.295	CbGaD
Mianserin—DRD2—Gilles de la Tourette syndrome	0.178	0.219	CbGaD
Mianserin—HTR2A—Gilles de la Tourette syndrome	0.138	0.169	CbGaD
Mianserin—SLC6A2—autonomic nervous system—Gilles de la Tourette syndrome	0.00434	0.0777	CbGeAlD
Mianserin—HTR7—autonomic nervous system—Gilles de la Tourette syndrome	0.00419	0.0749	CbGeAlD
Mianserin—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00261	0.0467	CbGeAlD
Mianserin—HTR1F—nervous system—Gilles de la Tourette syndrome	0.00168	0.03	CbGeAlD
Mianserin—HTR1F—central nervous system—Gilles de la Tourette syndrome	0.00161	0.0289	CbGeAlD
Mianserin—HTR1F—brain—Gilles de la Tourette syndrome	0.00128	0.0229	CbGeAlD
Mianserin—DRD3—nervous system—Gilles de la Tourette syndrome	0.00118	0.0212	CbGeAlD
Mianserin—DRD3—central nervous system—Gilles de la Tourette syndrome	0.00114	0.0204	CbGeAlD
Mianserin—HTR6—nervous system—Gilles de la Tourette syndrome	0.00114	0.0204	CbGeAlD
Mianserin—HTR6—central nervous system—Gilles de la Tourette syndrome	0.0011	0.0196	CbGeAlD
Mianserin—OPRK1—nervous system—Gilles de la Tourette syndrome	0.00106	0.0189	CbGeAlD
Mianserin—HRH2—nervous system—Gilles de la Tourette syndrome	0.00104	0.0186	CbGeAlD
Mianserin—OPRK1—central nervous system—Gilles de la Tourette syndrome	0.00102	0.0182	CbGeAlD
Mianserin—HRH2—central nervous system—Gilles de la Tourette syndrome	0.001	0.0179	CbGeAlD
Mianserin—DRD3—brain—Gilles de la Tourette syndrome	0.000905	0.0162	CbGeAlD
Mianserin—HTR6—brain—Gilles de la Tourette syndrome	0.000871	0.0156	CbGeAlD
Mianserin—SLC6A3—midbrain—Gilles de la Tourette syndrome	0.000829	0.0148	CbGeAlD
Mianserin—HTR1D—midbrain—Gilles de la Tourette syndrome	0.000809	0.0145	CbGeAlD
Mianserin—OPRK1—brain—Gilles de la Tourette syndrome	0.000806	0.0144	CbGeAlD
Mianserin—HTR2C—midbrain—Gilles de la Tourette syndrome	0.000801	0.0143	CbGeAlD
Mianserin—HRH2—brain—Gilles de la Tourette syndrome	0.000796	0.0142	CbGeAlD
Mianserin—SLC6A4—midbrain—Gilles de la Tourette syndrome	0.000759	0.0136	CbGeAlD
Mianserin—SLC6A3—nervous system—Gilles de la Tourette syndrome	0.000681	0.0122	CbGeAlD
Mianserin—HTR1A—midbrain—Gilles de la Tourette syndrome	0.000674	0.0121	CbGeAlD
Mianserin—HTR1D—nervous system—Gilles de la Tourette syndrome	0.000665	0.0119	CbGeAlD
Mianserin—HTR2C—nervous system—Gilles de la Tourette syndrome	0.000658	0.0118	CbGeAlD
Mianserin—SLC6A3—central nervous system—Gilles de la Tourette syndrome	0.000656	0.0117	CbGeAlD
Mianserin—HTR7—midbrain—Gilles de la Tourette syndrome	0.000644	0.0115	CbGeAlD
Mianserin—HTR1D—central nervous system—Gilles de la Tourette syndrome	0.00064	0.0114	CbGeAlD
Mianserin—Diphenylpyraline—SLC6A3—Gilles de la Tourette syndrome	0.000639	0.1	CrCbGaD
Mianserin—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000634	0.0113	CbGeAlD
Mianserin—SLC6A4—nervous system—Gilles de la Tourette syndrome	0.000624	0.0112	CbGeAlD
Mianserin—HTR2B—nervous system—Gilles de la Tourette syndrome	0.000619	0.0111	CbGeAlD
Mianserin—DRD2—midbrain—Gilles de la Tourette syndrome	0.000609	0.0109	CbGeAlD
Mianserin—SLC6A4—central nervous system—Gilles de la Tourette syndrome	0.000601	0.0107	CbGeAlD
Mianserin—HTR2B—central nervous system—Gilles de la Tourette syndrome	0.000595	0.0106	CbGeAlD
Mianserin—ADRA2C—midbrain—Gilles de la Tourette syndrome	0.000592	0.0106	CbGeAlD
Mianserin—HTR1A—nervous system—Gilles de la Tourette syndrome	0.000554	0.00991	CbGeAlD
Mianserin—SLC6A2—nervous system—Gilles de la Tourette syndrome	0.00055	0.00983	CbGeAlD
Mianserin—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.000534	0.00954	CbGeAlD
Mianserin—HTR7—nervous system—Gilles de la Tourette syndrome	0.00053	0.00947	CbGeAlD
Mianserin—SLC6A2—central nervous system—Gilles de la Tourette syndrome	0.000529	0.00946	CbGeAlD
Mianserin—SLC6A3—brain—Gilles de la Tourette syndrome	0.000521	0.00931	CbGeAlD
Mianserin—Mirtazapine—DRD4—Gilles de la Tourette syndrome	0.000517	0.0811	CrCbGaD
Mianserin—HTR7—central nervous system—Gilles de la Tourette syndrome	0.00051	0.00912	CbGeAlD
Mianserin—HTR1D—brain—Gilles de la Tourette syndrome	0.000508	0.00909	CbGeAlD
Mianserin—HTR2C—brain—Gilles de la Tourette syndrome	0.000503	0.009	CbGeAlD
Mianserin—DRD2—nervous system—Gilles de la Tourette syndrome	0.000501	0.00895	CbGeAlD
Mianserin—ADRA2C—nervous system—Gilles de la Tourette syndrome	0.000487	0.0087	CbGeAlD
Mianserin—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000482	0.00862	CbGeAlD
Mianserin—SLC6A4—brain—Gilles de la Tourette syndrome	0.000477	0.00853	CbGeAlD
Mianserin—HTR2B—brain—Gilles de la Tourette syndrome	0.000473	0.00845	CbGeAlD
Mianserin—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.000473	0.00845	CbGeAlD
Mianserin—ADRA2C—central nervous system—Gilles de la Tourette syndrome	0.000469	0.00838	CbGeAlD
Mianserin—Mirtazapine—DRD3—Gilles de la Tourette syndrome	0.000446	0.0699	CrCbGaD
Mianserin—HTR1A—brain—Gilles de la Tourette syndrome	0.000424	0.00757	CbGeAlD
Mianserin—SLC6A2—brain—Gilles de la Tourette syndrome	0.00042	0.00751	CbGeAlD
Mianserin—Mirtazapine—SLC6A3—Gilles de la Tourette syndrome	0.000415	0.0651	CrCbGaD
Mianserin—CYP2B6—nervous system—Gilles de la Tourette syndrome	0.000405	0.00724	CbGeAlD
Mianserin—HTR7—brain—Gilles de la Tourette syndrome	0.000405	0.00724	CbGeAlD
Mianserin—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000402	0.00718	CbGeAlD
Mianserin—HRH1—nervous system—Gilles de la Tourette syndrome	0.000395	0.00707	CbGeAlD
Mianserin—CYP2B6—central nervous system—Gilles de la Tourette syndrome	0.00039	0.00697	CbGeAlD
Mianserin—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.000388	0.00695	CbGeAlD
Mianserin—DRD2—brain—Gilles de la Tourette syndrome	0.000383	0.00684	CbGeAlD
Mianserin—HRH1—central nervous system—Gilles de la Tourette syndrome	0.000381	0.00681	CbGeAlD
Mianserin—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.000374	0.00669	CbGeAlD
Mianserin—ADRA2C—brain—Gilles de la Tourette syndrome	0.000372	0.00665	CbGeAlD
Mianserin—Prochlorperazine—DRD3—Gilles de la Tourette syndrome	0.000363	0.0568	CrCbGaD
Mianserin—HTR2A—nervous system—Gilles de la Tourette syndrome	0.00033	0.00591	CbGeAlD
Mianserin—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000318	0.00569	CbGeAlD
Mianserin—CYP2B6—brain—Gilles de la Tourette syndrome	0.00031	0.00553	CbGeAlD
Mianserin—Mirtazapine—DRD2—Gilles de la Tourette syndrome	0.000309	0.0484	CrCbGaD
Mianserin—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.000306	0.00547	CbGeAlD
Mianserin—Epinastine—HTR2A—Gilles de la Tourette syndrome	0.000303	0.0475	CrCbGaD
Mianserin—HRH1—brain—Gilles de la Tourette syndrome	0.000302	0.00541	CbGeAlD
Mianserin—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000301	0.00538	CbGeAlD
Mianserin—Cyproheptadine—DRD2—Gilles de la Tourette syndrome	0.000299	0.0469	CrCbGaD
Mianserin—ADRA2A—brain—Gilles de la Tourette syndrome	0.000297	0.00531	CbGeAlD
Mianserin—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.000294	0.00526	CbGeAlD
Mianserin—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.00029	0.00518	CbGeAlD
Mianserin—Trimipramine—SLC6A3—Gilles de la Tourette syndrome	0.000257	0.0402	CrCbGaD
Mianserin—HTR2A—brain—Gilles de la Tourette syndrome	0.000252	0.00451	CbGeAlD
Mianserin—Prochlorperazine—DRD2—Gilles de la Tourette syndrome	0.000251	0.0393	CrCbGaD
Mianserin—Mirtazapine—HTR2A—Gilles de la Tourette syndrome	0.000239	0.0374	CrCbGaD
Mianserin—Cyproheptadine—HTR2A—Gilles de la Tourette syndrome	0.000231	0.0363	CrCbGaD
Mianserin—CYP2D6—brain—Gilles de la Tourette syndrome	0.00023	0.00411	CbGeAlD
Mianserin—Desipramine—SLC6A3—Gilles de la Tourette syndrome	0.000224	0.0352	CrCbGaD
Mianserin—Amitriptyline—DRD3—Gilles de la Tourette syndrome	0.000203	0.0319	CrCbGaD
Mianserin—Nortriptyline—DRD2—Gilles de la Tourette syndrome	0.000203	0.0318	CrCbGaD
Mianserin—Trimipramine—DRD2—Gilles de la Tourette syndrome	0.000191	0.0299	CrCbGaD
Mianserin—Imipramine—SLC6A3—Gilles de la Tourette syndrome	0.00019	0.0298	CrCbGaD
Mianserin—Desipramine—DRD2—Gilles de la Tourette syndrome	0.000167	0.0262	CrCbGaD
Mianserin—Nortriptyline—HTR2A—Gilles de la Tourette syndrome	0.000157	0.0246	CrCbGaD
Mianserin—Trimipramine—HTR2A—Gilles de la Tourette syndrome	0.000148	0.0231	CrCbGaD
Mianserin—Imipramine—DRD2—Gilles de la Tourette syndrome	0.000142	0.0222	CrCbGaD
Mianserin—Amitriptyline—DRD2—Gilles de la Tourette syndrome	0.000141	0.0221	CrCbGaD
Mianserin—Desipramine—HTR2A—Gilles de la Tourette syndrome	0.000129	0.0202	CrCbGaD
Mianserin—Imipramine—HTR2A—Gilles de la Tourette syndrome	0.000109	0.0171	CrCbGaD
Mianserin—Amitriptyline—HTR2A—Gilles de la Tourette syndrome	0.000109	0.017	CrCbGaD
Mianserin—DRD3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.51e-05	0.00052	CbGpPWpGaD
Mianserin—ADRA2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.5e-05	0.000519	CbGpPWpGaD
Mianserin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	6.48e-05	0.000517	CbGpPWpGaD
Mianserin—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	6.44e-05	0.000514	CbGpPWpGaD
Mianserin—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.44e-05	0.000514	CbGpPWpGaD
Mianserin—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	6.43e-05	0.000513	CbGpPWpGaD
Mianserin—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6.31e-05	0.000504	CbGpPWpGaD
Mianserin—ADRA2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.31e-05	0.000504	CbGpPWpGaD
Mianserin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	6.29e-05	0.000502	CbGpPWpGaD
Mianserin—HTR1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.28e-05	0.000501	CbGpPWpGaD
Mianserin—HRH2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.25e-05	0.000499	CbGpPWpGaD
Mianserin—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.24e-05	0.000499	CbGpPWpGaD
Mianserin—HTR1F—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.11e-05	0.000488	CbGpPWpGaD
Mianserin—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6.09e-05	0.000487	CbGpPWpGaD
Mianserin—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.09e-05	0.000487	CbGpPWpGaD
Mianserin—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	6.08e-05	0.000485	CbGpPWpGaD
Mianserin—ADRA2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.07e-05	0.000485	CbGpPWpGaD
Mianserin—HRH2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.07e-05	0.000484	CbGpPWpGaD
Mianserin—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6.06e-05	0.000484	CbGpPWpGaD
Mianserin—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.06e-05	0.000484	CbGpPWpGaD
Mianserin—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.99e-05	0.000478	CbGpPWpGaD
Mianserin—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.9e-05	0.000471	CbGpPWpGaD
Mianserin—ADRA2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.9e-05	0.000471	CbGpPWpGaD
Mianserin—ADRA2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.88e-05	0.00047	CbGpPWpGaD
Mianserin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	5.86e-05	0.000468	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—HDC—Gilles de la Tourette syndrome	5.82e-05	0.000465	CbGpPWpGaD
Mianserin—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.68e-05	0.000453	CbGpPWpGaD
Mianserin—HRH2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.67e-05	0.000453	CbGpPWpGaD
Mianserin—HRH2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.65e-05	0.000451	CbGpPWpGaD
Mianserin—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.65e-05	0.000451	CbGpPWpGaD
Mianserin—SLC6A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	5.52e-05	0.000441	CbGpPWpGaD
Mianserin—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.51e-05	0.00044	CbGpPWpGaD
Mianserin—HRH2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.51e-05	0.00044	CbGpPWpGaD
Mianserin—ADRA2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.49e-05	0.000439	CbGpPWpGaD
Mianserin—OPRK1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.45e-05	0.000435	CbGpPWpGaD
Mianserin—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.42e-05	0.000433	CbGpPWpGaD
Mianserin—HRH1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.41e-05	0.000432	CbGpPWpGaD
Mianserin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.41e-05	0.000432	CbGpPWpGaD
Mianserin—HTR6—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.37e-05	0.000429	CbGpPWpGaD
Mianserin—HTR7—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.37e-05	0.000428	CbGpPWpGaD
Mianserin—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.35e-05	0.000427	CbGpPWpGaD
Mianserin—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.35e-05	0.000427	CbGpPWpGaD
Mianserin—HTR1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.33e-05	0.000426	CbGpPWpGaD
Mianserin—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.26e-05	0.00042	CbGpPWpGaD
Mianserin—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.25e-05	0.000419	CbGpPWpGaD
Mianserin—HRH1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.25e-05	0.000419	CbGpPWpGaD
Mianserin—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.22e-05	0.000417	CbGpPWpGaD
Mianserin—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.19e-05	0.000415	CbGpPWpGaD
Mianserin—HRH2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.13e-05	0.00041	CbGpPWpGaD
Mianserin—HRH4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.1e-05	0.000408	CbGpPWpGaD
Mianserin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.05e-05	0.000403	CbGpPWpGaD
Mianserin—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	4.93e-05	0.000394	CbGpPWpGaD
Mianserin—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.9e-05	0.000392	CbGpPWpGaD
Mianserin—HTR2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.9e-05	0.000391	CbGpPWpGaD
Mianserin—HRH1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.89e-05	0.000391	CbGpPWpGaD
Mianserin—OPRK1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.86e-05	0.000388	CbGpPWpGaD
Mianserin—HTR6—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.79e-05	0.000383	CbGpPWpGaD
Mianserin—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	4.79e-05	0.000382	CbGpPWpGaD
Mianserin—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	4.79e-05	0.000382	CbGpPWpGaD
Mianserin—HTR7—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.79e-05	0.000382	CbGpPWpGaD
Mianserin—HTR1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.76e-05	0.00038	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	4.73e-05	0.000378	CbGpPWpGaD
Mianserin—OPRK1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.72e-05	0.000377	CbGpPWpGaD
Mianserin—HTR1F—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.71e-05	0.000376	CbGpPWpGaD
Mianserin—HTR6—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.65e-05	0.000371	CbGpPWpGaD
Mianserin—HTR7—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.65e-05	0.000371	CbGpPWpGaD
Mianserin—HRH4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.64e-05	0.00037	CbGpPWpGaD
Mianserin—HTR1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.62e-05	0.000369	CbGpPWpGaD
Mianserin—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.58e-05	0.000366	CbGpPWpGaD
Mianserin—DRD3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.56e-05	0.000364	CbGpPWpGaD
Mianserin—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.5e-05	0.000359	CbGpPWpGaD
Mianserin—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.46e-05	0.000356	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—HDC—Gilles de la Tourette syndrome	4.44e-05	0.000354	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.42e-05	0.000353	CbGpPWpGaD
Mianserin—OPRK1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.4e-05	0.000351	CbGpPWpGaD
Mianserin—HTR2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.37e-05	0.000349	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.35e-05	0.000347	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.35e-05	0.000347	CbGpPWpGaD
Mianserin—HTR6—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.33e-05	0.000346	CbGpPWpGaD
Mianserin—HTR7—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.33e-05	0.000346	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.32e-05	0.000345	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.32e-05	0.000345	CbGpPWpGaD
Mianserin—HTR1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.3e-05	0.000343	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.29e-05	0.000342	CbGpPWpGaD
Mianserin—HTR1F—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.28e-05	0.000342	CbGpPWpGaD
Mianserin—HTR2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.25e-05	0.000339	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.22e-05	0.000337	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.22e-05	0.000337	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.2e-05	0.000335	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.19e-05	0.000335	CbGpPWpGaD
Mianserin—ADRA2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.12e-05	0.000329	CbGpPWpGaD
Mianserin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.1e-05	0.000328	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.99e-05	0.000319	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.99e-05	0.000319	CbGpPWpGaD
Mianserin—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.98e-05	0.000317	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.97e-05	0.000317	CbGpPWpGaD
Mianserin—HRH2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.96e-05	0.000316	CbGpPWpGaD
Mianserin—HTR2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.96e-05	0.000316	CbGpPWpGaD
Mianserin—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.96e-05	0.000316	CbGpPWpGaD
Mianserin—DRD3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.95e-05	0.000316	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.94e-05	0.000314	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.93e-05	0.000314	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.91e-05	0.000312	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.91e-05	0.000312	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.87e-05	0.000309	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.86e-05	0.000308	CbGpPWpGaD
Mianserin—ADRA2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.85e-05	0.000307	CbGpPWpGaD
Mianserin—DRD3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.68e-05	0.000294	CbGpPWpGaD
Mianserin—ADRA2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.67e-05	0.000293	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.61e-05	0.000288	CbGpPWpGaD
Mianserin—HRH2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.59e-05	0.000287	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.59e-05	0.000287	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.59e-05	0.000287	CbGpPWpGaD
Mianserin—ADRA2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.57e-05	0.000285	CbGpPWpGaD
Mianserin—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.55e-05	0.000283	CbGpPWpGaD
Mianserin—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.53e-05	0.000282	CbGpPWpGaD
Mianserin—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.49e-05	0.000279	CbGpPWpGaD
Mianserin—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.44e-05	0.000275	CbGpPWpGaD
Mianserin—ADRA2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.43e-05	0.000274	CbGpPWpGaD
Mianserin—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.43e-05	0.000274	CbGpPWpGaD
Mianserin—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.43e-05	0.000274	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.35e-05	0.000268	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.34e-05	0.000267	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.34e-05	0.000266	CbGpPWpGaD
Mianserin—ADRA2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.33e-05	0.000266	CbGpPWpGaD
Mianserin—ADRA2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.32e-05	0.000265	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.25e-05	0.00026	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.24e-05	0.000259	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.22e-05	0.000257	CbGpPWpGaD
Mianserin—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.21e-05	0.000256	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.2e-05	0.000256	CbGpPWpGaD
Mianserin—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.19e-05	0.000255	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.13e-05	0.00025	CbGpPWpGaD
Mianserin—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.12e-05	0.00025	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.12e-05	0.000249	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.11e-05	0.000249	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.11e-05	0.000248	CbGpPWpGaD
Mianserin—ADRA2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.1e-05	0.000248	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	3.08e-05	0.000246	CbGpPWpGaD
Mianserin—OPRK1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.08e-05	0.000246	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.06e-05	0.000245	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.06e-05	0.000244	CbGpPWpGaD
Mianserin—HTR6—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.04e-05	0.000242	CbGpPWpGaD
Mianserin—HTR7—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.03e-05	0.000242	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.03e-05	0.000242	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.03e-05	0.000242	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.02e-05	0.000241	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.02e-05	0.000241	CbGpPWpGaD
Mianserin—HTR1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.01e-05	0.000241	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.98e-05	0.000238	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.97e-05	0.000237	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.91e-05	0.000233	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.9e-05	0.000231	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.83e-05	0.000226	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.82e-05	0.000225	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.8e-05	0.000223	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.79e-05	0.000223	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.78e-05	0.000222	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.78e-05	0.000222	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.77e-05	0.000221	CbGpPWpGaD
Mianserin—HTR2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.77e-05	0.000221	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.77e-05	0.000221	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.76e-05	0.00022	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.75e-05	0.00022	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.75e-05	0.000219	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.74e-05	0.000219	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.74e-05	0.000218	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.71e-05	0.000216	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.7e-05	0.000216	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.7e-05	0.000215	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	2.61e-05	0.000209	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.61e-05	0.000208	CbGpPWpGaD
Mianserin—DRD3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.58e-05	0.000206	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.57e-05	0.000205	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.57e-05	0.000205	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.55e-05	0.000204	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.53e-05	0.000202	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.53e-05	0.000202	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.53e-05	0.000202	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.52e-05	0.000201	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.52e-05	0.000201	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.52e-05	0.000201	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.51e-05	0.000201	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.5e-05	0.000199	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.49e-05	0.000199	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.48e-05	0.000198	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.46e-05	0.000196	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.36e-05	0.000188	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.35e-05	0.000187	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.34e-05	0.000187	CbGpPWpGaD
Mianserin—ADRA2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.33e-05	0.000186	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.32e-05	0.000186	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.32e-05	0.000185	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.31e-05	0.000184	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.29e-05	0.000183	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.28e-05	0.000182	CbGpPWpGaD
Mianserin—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.25e-05	0.000179	CbGpPWpGaD
Mianserin—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.24e-05	0.000178	CbGpPWpGaD
Mianserin—ADRA2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.17e-05	0.000174	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.12e-05	0.00017	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.12e-05	0.000169	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.12e-05	0.000169	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.11e-05	0.000169	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.04e-05	0.000163	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.03e-05	0.000162	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	2.02e-05	0.000161	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.97e-05	0.000158	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.97e-05	0.000158	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.97e-05	0.000158	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.97e-05	0.000157	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.94e-05	0.000155	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.91e-05	0.000153	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.9e-05	0.000152	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.89e-05	0.000151	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.85e-05	0.000148	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.84e-05	0.000147	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.84e-05	0.000147	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.79e-05	0.000143	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.79e-05	0.000143	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.78e-05	0.000142	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.77e-05	0.000141	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.76e-05	0.00014	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.72e-05	0.000137	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.71e-05	0.000137	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.67e-05	0.000133	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.67e-05	0.000133	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.65e-05	0.000132	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.64e-05	0.000131	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.64e-05	0.000131	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.63e-05	0.00013	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.63e-05	0.00013	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.62e-05	0.00013	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.62e-05	0.000129	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.6e-05	0.000128	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.6e-05	0.000127	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.59e-05	0.000127	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.5e-05	0.000119	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.49e-05	0.000119	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.49e-05	0.000119	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.48e-05	0.000118	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.45e-05	0.000116	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.38e-05	0.00011	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.35e-05	0.000108	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.25e-05	9.97e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.21e-05	9.62e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.2e-05	9.58e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.17e-05	9.31e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.06e-05	8.45e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.04e-05	8.3e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.47e-06	7.56e-05	CbGpPWpGaD
